These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1092954

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Studies on monoamine oxidase. (Report 37) Effects of oxygen concentration on rat liver and brain monoamine oxidase (author's transl)].
    Nakagawa K.
    Nihon Yakurigaku Zasshi; 1977 Apr; 73(3):297-305. PubMed ID: 21126
    [Abstract] [Full Text] [Related]

  • 24. Monoamine oxidase activities in catfish (Parasilurus asotus) tissues.
    Kumazawa T, Seno H, Ishii A, Suzuki O, Sato K.
    J Enzyme Inhib; 1998 Aug; 13(5):377-84. PubMed ID: 9793841
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of monoamine oxidase isoforms in human islets of Langerhans.
    Pizzinat N, Chan SL, Remaury A, Morgan NG, Parini A.
    Life Sci; 1999 Aug; 65(4):441-8. PubMed ID: 10421430
    [Abstract] [Full Text] [Related]

  • 27. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB.
    J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
    Finberg JP, Tenne M.
    Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
    Kinemuchi H, Sudo M, Yoshino M, Kawaguchi T, Sunami Y, Kamijo K.
    Life Sci; 1983 Jan 31; 32(5):517-24. PubMed ID: 6823208
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):20-30. PubMed ID: 17056035
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chlorphentermine inhibits pulmonary mitochondrial monoamine oxidase.
    Zychlinski L, Montgomery MR.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985 Dec 15; 82(2):389-94. PubMed ID: 2866910
    [Abstract] [Full Text] [Related]

  • 38. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 15; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 39. Monoamine oxidase and catechol-O-methyl transferase activity in Tetrahymena.
    Feldman JM, Roche JM, Blum JJ.
    J Protozool; 1977 Aug 15; 24(3):459-62. PubMed ID: 21289
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 15; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.